Laboratory and Biochemical Markers
Cross-source consensus on Laboratory and Biochemical Markers from 1 sources and 6 claims.
1 sources · 6 claims
Risks & contraindications
Highlighted claims
- Multiple laboratory abnormalities were significantly associated with severity, including renal, liver, protein, inflammatory, coagulation, and immune markers. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Blood group, antibody status, and viral load were not significantly associated with symptom severity. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Category 5 patients had higher odds of lymphopenia. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Fasting blood glucose and several metabolic or electrolyte markers were significantly associated with severity. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Triglycerides were not significantly associated with severity. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study
- Elevated fasting blood glucose was linked with higher odds of category 4 severity, although reported odds ratios differed between results and discussion. — Risk factors for COVID-19 symptom severity across clinical categories among hospitalised patients in Kuala Lumpur, Malaysia: a prospective cohort study